Skip to Main Content

Paper Details

Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial.
JACC Heart Fail
0
2024
Cardiomyopathy, HCM, HTN, Hypertension, MYK-461, Mavacamten, NT pro-B-type natriuretic peptide, Obstructive Hypertrophic Cardiomyopathy, Patients, cardiac myosin, hypertrophic cardiomyopathy, mavacamten, obstructive HCM, oxygen, patients
Author NameAffiliation
John A SpertusUniversity of Missouri-Kansas City School of Medicine
John A SpertusUniversity of Missouri-Kansas City School of Medicine
  • 1 - 2

Datasets

Release 1.2